Publications
17 publications
Funding
3 grants
Active
1 grant- KPUBR5's Mechanisms of Action in Tumorigenesis and ImmunoregulationNational Cancer Institute · 2023–2028
Completed grants (2)
- KPInvestigation of UBR5 and its signaling as a novel target for breast cancer therapyU.S. Department of Defense · 2021–2025W81XWH-21-1-0261
- KPUBR5, E3 Ubiquitin Ligase, in Triple Negative Breast Cancers: Potential Role in Anti-Tumor Immunity and Cancer MetaboQatar National Research Fund · 2020–2024 · via Weill Cornell Medical College/QatarNPRP-S 12-0317-190379